Drug Topics A study shows young adults with 3 or more COVID-19 vaccine doses experience fewer symptoms, emphasizing vaccination’s critical role in public health.
Young adults—aged 16 to 35 years—who received 3 or more doses of the COVID-19 vaccine had a lower incidence of symptoms, including headache and olfactory reduction, according to results of a study published in BMC Infectious Diseases. Investigators said that the results highlight the importance of vaccination to reduce the severity of COVID-19 symptoms.1
“Our study highlights that vaccination status, particularly with 3 or more doses, is associated with reduced incidence of symptoms such as headache and olfactory reduction in young adults,” the study authors said. “These findings highlight the critical role of vaccination among young adults in reducing the severity of COVID-19 symptoms and offer important insights for shaping future public health strategies and vaccine policies.”